Medical Devices Startups

Forma Medical develops OptimalMTP, a minimally invasive surgical system for first metatarsophalangeal joint arthrodesis that combines plate-and-screw biomechanics with smaller incision techniques for foot surgeons.

2 investors

Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System. It plans to expand into bladder and kidney cancer applications, aiming to reduce the side effects associated with conventional prostate treatments.

2 investors

Freedom One Life builds the Series 5, a premium electric powered wheelchair designed by a powerchair user for both everyday use and outdoor adventures, offering up to 60km range and hybrid indoor/outdoor capability. The company serves people with mobility needs and offers nationwide test drives in the UK.

2 investors

Fundamental VR develops immersive extended reality (XR) training solutions for clinical and medical device professionals, enabling faster skill acquisition and competency development through interactive 3D simulations and digital twins of medical procedures.

2 investors

FUS Mobile develops the Neurolyser XR, a non-invasive, fluoroscopy-guided ablative therapy platform for treating chronic low back pain caused by arthritis of the vertebral facet joints. The medical device targets patients and physicians as an alternative to invasive standard-of-care procedures.

2 investors

Gain Therapeutics develops small molecule drugs for neurodegenerative diseases using an AI-powered drug discovery platform that identifies novel binding sites on disease-related proteins. The company's lead candidate, rexaceract, targets GBA-Parkinson's disease and is in Phase I clinical trials.

2 investors

Galera Therapeutics is a biotechnology company developing antibody-based and other therapeutics. This page profiles Dr. Nancy Chang, a member of the company's Board of Directors.

2 investors

GelSana Therapeutics develops zwitterionic polymer-based biomaterials for wound care, addressing excess sustained inflammation that impedes healing. Its first product, CleraFlex, is a shelf-stable wound dressing designed to reduce inflammation, repel bacteria, balance moisture, and provide a protective barrier.

2 investors

GenePath provides molecular diagnostic and genomic testing services and products for infectious diseases, oncology, and inherited genetic disorders, serving clinical healthcare and research markets globally since 2008.

2 investors

Genkore develops ultra-compact gene-editing technology to create therapeutic treatments for neurodegenerative diseases such as Huntington's and ALS. The company's gene scissors technology offers advantages in gene editing efficiency and delivery compared to existing approaches.

2 investors

Genese Technologies makes mediscan, a portable AI-based health screening device (device, belt, and app) that performs non-invasive preventative screening and chronic disease monitoring for liver, lung, and kidney health. It generates personalized health reports in minutes for use in clinics, community centers, at-home, corporate wellness, and telemedicine settings.

2 investors

Gisens Biotech develops G-LoC, a portable graphene-based biochip technology that delivers rapid health monitoring and diagnostic test results from home samples in minutes rather than days. The company's initial product, KF4+, is designed for patients with chronic kidney disease to perform comprehensive kidney function testing at home with results integrated into electronic health records.

2 investors

Global Vascular develops medical devices based on its BioDiamond Technology, including antithrombotic diamond (F-DLC) coatings, drug-eluting stents, and catheters for vascular and interventional treatments. The company emerged from a medical-engineering research collaboration between Keio University and Tokai University in Japan.

2 investors

Gordian Surgical develops the TroClose, an FDA-cleared integrated trocar and wound closure device that combines laparoscopic port access with automated port-site closure. The product is aimed at laparoscopic surgeons to improve operating room efficiency and patient outcomes while reducing hernia rates and post-operative pain.

2 investors

Granite Bio develops first-in-class therapeutic antibodies targeting inflammation, autoimmunity, and fibrosis for patients lacking effective treatment options. The company is based in Basel, Switzerland, with a pipeline including Minokitug for autoimmune inflammation and GRT-002 for allergy and itch conditions.

2 investors

GrayMatters Health develops Prism, an interventional psychiatry suite that uses fMRI-informed EEG digital biomarkers and self-neuromodulation to help patients regulate brain activity linked to conditions such as PTSD and depression. It is sold to psychiatry clinics to augment standard-of-care therapies.

2 investors

GreenBone develops biomimetic bone substitutes derived from rattan wood for orthopedic surgery applications including trauma repair, bone augmentation, and reconstruction. The company serves surgeons and patients requiring bone regeneration solutions.

2 investors

Greenlight Guru provides quality management, product development, and clinical evidence software built specifically for medical device companies. Its platform helps medtech teams manage compliance, design controls, risk, and clinical data collection across the product lifecycle.

2 investors

greenteg develops and manufactures certified heat flux and temperature sensors in Switzerland, including its CORE/calera gSKIN technology, which are integrated into wearables for health monitoring, sports, medtech, and building U-value measurement. Founded as a spin-off of ETH Zurich, it serves engineers, scientists, research teams, and consumer wearable partners worldwide.</parameter> <parameter name="founders">[]

2 investors

GT Metabolic develops magnetic compression anastomosis technology, including its MagDI System, which uses magnets to create incisionless, sutureless duodeno-ileal anastomoses during bariatric surgery. The technique is intended to support weight loss and glycemic control in obese patients with or without type 2 diabetes, and its products have received FDA marketing authorization and clearances.

2 investors

H3D builds an AI platform called AutoDesign that automates the design of custom-fit products, replacing manual CAD work for hearing labs (hearing aids, hearing protection, consumer audio) and dental labs. The company serves labs globally in the medical device and consumer technology industries, using AI, 3D, image processing and cloud computing.

2 investors

Haermonics is a clinical-stage medtech company that developed the Haermonics Pure System, a continuous postoperative pericardial flush therapy designed to keep chest tubes clear and prevent bleeding-related complications after open-heart cardiac surgery. The device targets retained blood syndrome and the need for surgical re-exploration in cardiac surgery patients.

2 investors

Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders. Its lead technology, SynthoPlate, is a fully-synthetic hemostatic agent that acts at the injury site to amplify the body's natural clotting mechanisms.

2 investors

Haplotype Labs develops population genetics software and polygenic risk scores with improved security, accessibility, and sophistication to enhance human healthspan. The company serves researchers, healthcare providers, and consumers seeking genetic risk assessment tools.

2 investors